Back to Search
Start Over
High-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888
- Source :
- PLoS ONE, Vol 6, Iss 3, p e17692 (2011), PLoS ONE
- Publication Year :
- 2011
- Publisher :
- Public Library of Science (PLoS), 2011.
-
Abstract
- BackgroundMany proteins that are dysregulated or mutated in cancer cells rely on the molecular chaperone HSP90 for their proper folding and activity, which has led to considerable interest in HSP90 as a cancer drug target. The diverse array of HSP90 client proteins encompasses oncogenic drivers, cell cycle components, and a variety of regulatory factors, so inhibition of HSP90 perturbs multiple cellular processes, including mitogenic signaling and cell cycle control. Although many reports have investigated HSP90 inhibition in the context of the cell cycle, no large-scale studies have examined potential correlations between cell genotype and the cell cycle phenotypes of HSP90 inhibition.Methodology/principal findingsTo address this question, we developed a novel high-content, high-throughput cell cycle assay and profiled the effects of two distinct small molecule HSP90 inhibitors (XL888 and 17-AAG [17-allylamino-17-demethoxygeldanamycin]) in a large, genetically diverse panel of cancer cell lines. The cell cycle phenotypes of both inhibitors were strikingly similar and fell into three classes: accumulation in M-phase, G2-phase, or G1-phase. Accumulation in M-phase was the most prominent phenotype and notably, was also correlated with TP53 mutant status. We additionally observed unexpected complexity in the response of the cell cycle-associated client PLK1 to HSP90 inhibition, and we suggest that inhibitor-induced PLK1 depletion may contribute to the striking metaphase arrest phenotype seen in many of the M-arrested cell lines.Conclusions/significanceOur analysis of the cell cycle phenotypes induced by HSP90 inhibition in 25 cancer cell lines revealed that the phenotypic response was highly dependent on cellular genotype as well as on the concentration of HSP90 inhibitor and the time of treatment. M-phase arrest correlated with the presence of TP53 mutations, while G2 or G1 arrest was more commonly seen in cells bearing wt TP53. We draw upon previous literature to suggest an integrated model that accounts for these varying observations.
- Subjects :
- Time Factors
Lactams, Macrocyclic
Science
Phthalic Acids
Mitosis
Cell Cycle Proteins
HSP90 Heat-Shock Proteins
Synthesis Phase
Protein Serine-Threonine Kinases
Biology
Cell Growth
Cell Line
03 medical and health sciences
Fluorescence-Activated Cell Sorting
0302 clinical medicine
Proto-Oncogene Proteins
Drug Discovery
Molecular Cell Biology
Basic Cancer Research
Benzoquinones
Humans
Image Cytometry
Cellular Stress Responses
030304 developmental biology
Genetics
0303 health sciences
Multidisciplinary
Cell Cycle
Flow Cytometry
High-Throughput Screening Assays
3. Good health
High throughput analysis
Cell staining
Oncology
030220 oncology & carcinogenesis
Genome Biology
Medicine
Azabicyclo Compounds
Cell Division
Cytometry
Research Article
Biotechnology
Subjects
Details
- Language :
- English
- ISSN :
- 19326203
- Volume :
- 6
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- PLoS ONE
- Accession number :
- edsair.doi.dedup.....e1429f7929e153bcbf9fc02535487eba